Clover Health Investments (CLOV) Cash & Current Investments (2019 - 2026)

Clover Health Investments (CLOV) has 8 years of Cash & Current Investments data on file, last reported at $197.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 23.34% year-over-year to $197.5 million; the trailing twelve-month figure through Mar 2026 stood at $197.5 million (up 23.34% YoY), and the FY2025 full-year result was $80.1 million, down 58.84% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $197.5 million, up from $80.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $536.7 million in Q3 2022 and bottomed at $80.1 million in Q4 2025.
• The 5-year median for Cash & Current Investments is $264.4 million (2024), against an average of $271.6 million.
• The widest annual swing landed in 2022, when Cash & Current Investments surged 149.12%; it then sank 58.84% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $293.3 million in 2022, then tumbled by 53.94% to $135.1 million in 2023, then surged by 44.03% to $194.6 million in 2024, then tumbled by 58.84% to $80.1 million in 2025, then surged by 146.58% to $197.5 million in 2026.
• The last three Cash & Current Investments figures came in at $197.5 million (Q1 2026), $80.1 million (Q4 2025), and $201.0 million (Q3 2025), per Business Quant data.

Peer Comparison